Published in Arzneimittelforschung on January 01, 2009
Novel treatment options for portal hypertension. Gastroenterol Rep (Oxf) (2017) 0.75
Aspergillus oryzae GB-107 fermentation improves nutritional quality of food soybeans and feed soybean meals. J Med Food (2004) 1.29
Novel antioxidant ameliorates the fibrosis and inflammation of cerulein-induced chronic pancreatitis in a mouse model. Pancreatology (2005) 1.09
Mechanism of erectogenic effect of the selective phosphodiesterase type 5 inhibitor, DA-8159. Arch Pharm Res (2002) 1.09
Protective effect of Aloe vera on polymicrobial sepsis in mice. Food Chem Toxicol (2009) 1.05
Protective effect of baicalin against carbon tetrachloride-induced acute hepatic injury in mice. J Pharmacol Sci (2008) 1.02
DA-9601 for erosive gastritis: results of a double-blind placebo-controlled phase III clinical trial. World J Gastroenterol (2004) 0.97
Determination of a new phosphodiesterase V inhibitor, DA-8159, in plasma and urine by high-performance liquid chromatography. J Pharm Biomed Anal (2002) 0.95
The therapeutic effect of DA-6034 on ocular inflammation via suppression of MMP-9 and inflammatory cytokines and activation of the MAPK signaling pathway in an experimental dry eye model. Curr Eye Res (2010) 0.92
Effects of DA-6034, a flavonoid derivative, on mucin-like glycoprotein and ocular surface integrity in a rabbit model. Arzneimittelforschung (2009) 0.89
Beneficial effects of the combination of amlodipine and losartan for lowering blood pressure in spontaneously hypertensive rats. Arch Pharm Res (2009) 0.89
Effects of phosphodiesterase type 5 inhibitor on the contractility of prostate tissues and urethral pressure responses in a rat model of benign prostate hyperplasia. Int J Urol (2007) 0.88
Gastroprotective effects of DA-6034, a new flavonoid derivative, in various gastric mucosal damage models. Dig Dis Sci (2007) 0.88
Disinfection kinetics of murine norovirus using chlorine and chlorine dioxide. Water Res (2010) 0.87
Characterization of ozone disinfection of murine norovirus. Appl Environ Microbiol (2009) 0.87
Inhibitory effects of 7-carboxymethyloxy-3',4',5-trimethoxyflavone (DA-6034) on Helicobacter pylori-induced NF-kappa B activation and iNOS expression in AGS cells. Ann N Y Acad Sci (2007) 0.84
Characterization and immunopotentiating effects of the glycoprotein isolated from dioscorea batatas. Korean J Physiol Pharmacol (2011) 0.84
Transport of a new erectogenic udenafil in Caco-2 cells. Arch Pharm Res (2007) 0.84
Pulmonary thromboembolism after tourniquet inflation under spinal anesthesia -A case report-. Korean J Anesthesiol (2010) 0.83
Chronic administration of udenafil, a selective phosphodiesterase type 5 inhibitor, promotes erectile function recovery in an animal model of bilateral cavernous nerve crush injury. J Sex Med (2011) 0.83
Candidate molecule for premature ejaculation, DA-8031: in vivo and in vitro characterization of DA-8031. Urology (2011) 0.82
Discovery of DA-1229: a potent, long acting dipeptidyl peptidase-4 inhibitor for the treatment of type 2 diabetes. Bioorg Med Chem Lett (2011) 0.82
Simultaneous determination of sildenafil and its active metabolite UK-103,320 in human plasma using liquid chromatography-tandem mass spectrometry. J Pharm Biomed Anal (2003) 0.82
Investigation of norovirus occurrence in groundwater in metropolitan Seoul, Korea. Sci Total Environ (2011) 0.82
Pharmacokinetics and biodistribution of a pGT2-VEGF plasmid DNA after administration in rats. J Cardiovasc Pharmacol (2005) 0.82
Gastroretentive drug delivery system of DA-6034, a new flavonoid derivative, for the treatment of gastritis. Int J Pharm (2008) 0.81
Microarray analysis of gene expression profile in the corpus cavernosum of hypercholesterolemic rats after chronic treatment with PDE5 inhibitor. Life Sci (2006) 0.80
Effects of DA-6034 on aqueous tear fluid secretion and conjunctival goblet cell proliferation. J Ocul Pharmacol Ther (2009) 0.79
Effects of chronic alcohol consumption on expression levels of APP and Aβ-producing enzymes. BMB Rep (2011) 0.79
In vitro and in vivo activities of DA-7867, a new oxazolidinone, against aerobic gram-positive bacteria. Antimicrob Agents Chemother (2005) 0.79
Effect of SA1, a herbal formulation, on sexual behavior and penile erection. Biol Pharm Bull (2006) 0.78
Udenafil enhances the recovery of erectile function and ameliorates the pathophysiological consequences of cavernous nerve resection. J Sex Med (2010) 0.78
Pharmacokinetics of oral amlodipine orotate in vagotomized dogs. Biopharm Drug Dispos (2006) 0.78
Pharmacokinetics of DA-7218, a new oxazolidinone, and its active metabolite, DA-7157, after intravenous and oral administration of DA-7218 and DA-7157 to rats. J Pharm Pharmacol (2007) 0.78
Effects of water deprivation on the pharmacokinetics of DA-8159, a new erectogenic, in rats. J Pharm Pharm Sci (2006) 0.78
Inhibitory effect of DA-9201, an extract of Oryza sativa L., on airway inflammation and bronchial hyperresponsiveness in mouse asthma model. Biol Pharm Bull (2006) 0.77
Pharmacokinetics of 7-carboxymethyloxy-3',4',5-trimethoxy flavone (DA-6034), a derivative of flavonoid, in mouse and rat models of chemically-induced inflammatory bowel disease. J Pharm Pharmacol (2006) 0.77
Erectile potentials of a new phosphodiesterase type 5 inhibitor, DA-8159, in diet-induced obese rats. Asian J Androl (2006) 0.77
Pharmacokinetics of DA-6034, an agent for inflammatory bowel disease, in rats and dogs: Contribution of intestinal first-pass effect to low bioavailability in rats. Eur J Pharm Sci (2006) 0.76
Long-acting interferon-alpha 2a modified with a trimer-structured polyethylene glycol: preparation, in vitro bioactivity, in vivo stability and pharmacokinetics. Int J Pharm (2006) 0.75
Anti-diabetic effects of DA-11004, a synthetic IDPc inhibitor in high fat high sucrose diet-fed C57BL/6J mice. Arch Pharm Res (2004) 0.75
Penile erectile responses to electric stimulation are enhanced by a new phosphodiesterase type-5 inhibitor. Int J Urol (2005) 0.75
DA-9201 shows anti-asthmatic effects by suppressing NF-kappaB expression in an ovalbumin-induced mouse model of asthma. Arch Pharm Res (2005) 0.75
Effects of water deprivation for 72 hours on the pharmacokinetics of DA-7867, a new oxazolidinone, in rats. Biopharm Drug Dispos (2006) 0.75
Gender differences in the pharmacokinetics of DA-6034, a derivative of flavonoids, in rats. Biopharm Drug Dispos (2006) 0.75
Negligible pharmacokinetic interaction between oral DA-8159, a new erectogenic, and amlodipine in rats. Biopharm Drug Dispos (2006) 0.75
Effect of Oryza sativa extract on the progression of airway inflammation and remodeling in an experimental animal model of asthma. Planta Med (2006) 0.75